Drug Shortage Report for APO-LATANOPROST
Report ID | 157695 |
Drug Identification Number | 02296527 |
Brand name | APO-LATANOPROST |
Common or Proper name | LATANOPROST |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | LATANOPROST |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 2.5ML |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-29 |
Estimated end date | 2022-09-23 |
Actual end date | 2022-09-21 |
Shortage status | Resolved |
Updated date | 2022-09-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-09-23 | French | Compare |
v5 | 2022-09-23 | English | Compare |
v4 | 2022-07-15 | French | Compare |
v3 | 2022-07-15 | English | Compare |
v2 | 2022-04-01 | French | Compare |
v1 | 2022-04-01 | English | Compare |
Showing 1 to 6 of 6